Thromboxane modulates endothelial permeability

J. M. Klausner, S. Abu-Abid, G. Goldman, H. B. Hechtman, C. R. Valeri, J. S. Alexander, R. Hanshke-Mineau, N. Morel, D. Shepro

Research output: Contribution to journalArticlepeer-review


This study tests the role of thromboxane in modulating microvascular permeability in vitro. Cultured monolayers of bovine aortic endothelial cells were challenged with the thromboxane (Tx) mimic U46619. This led to disassembly of actin microfilaments, cell rounding, border retraction and interendothelial gap formation. Pretreatment with the Tx receptor antagonist SQ 29,548 prevented the Tx mimic-induced cytoskeletal changes. The Tx mimic also altered endothelial cell barrier function. Increased permeability was indicated by the increased passage of labelled albumin across monolayers cultured on microcarriers, relative to untreated endothelial cells (p < 0.05). Furthermore, electron microscopy of endothelial cells cultured on the basement membrane of human placental amnion indicated increased permeability based on wide, interendothelial gap formation and transit of the tracer horseradish peroxidase. Quantification of interendothelial gaps revealed an eleven-fold increase with the Tx mimic relative to untreated endothial cells (p < 0.05) and prevention by pretreatment with the Tx receptor antagonist (p < 0.05). These data indicate that Tx directly modulates the permeability of endothelial cells in vitro.

Original languageEnglish
Pages (from-to)149-153
Number of pages5
JournalMediators of Inflammation
Issue number2
StatePublished - 1994


  • Cytoskeleton
  • Endothelium
  • Permeability
  • Thromboxane


Dive into the research topics of 'Thromboxane modulates endothelial permeability'. Together they form a unique fingerprint.

Cite this